 |
 |

Psoralen Bath Plus UV-A TherapyPossibilities and Limitations
Matthias Lüftl, MD;
Klaus Degitz, MD;
Gerd Plewig, MD;
Martin Röcken, MD
Arch Dermatol. 1997;133(12):1597-1603.
Abstract
 |  |
Oral psoralen plus UV-A (PUVA) therapy was originally developed for the treatment of vitiligo.1,2 With the introduction of potent UV-A irradiation sources between 1972 and 1974, UV-A irradiation following psoralen application was found to be a highly efficient therapy for proriasis.3-5 The acronym PUVA was created and the potential use of PUVA was investigated in a large spectrum of different inflammatory and neoplastic skin diseases.6-8 Psoralen plus UV-A has profoundly influenced the therapeutic concepts of dermatology, as demonstrated in the recent review by Honig et al.8 An alternative approach, psoralen bath plus UV-A therapy (PUVA bath therapy) that avoids the adverse effects associated with oral PUVA therapy has increasingly been used during recent years. Psoralen bath plus UV-A therapy is not simply a technical variant of photochemotherapy; it is obviously superior to oral PUVA, at least for some indications, and it has considerably enlarged the spectrum of diseases responsive to photochemotherapy.
Author Affiliations
From the Department of Dermatology, Ludwig-Maximilians-University of Munich, Munich, Germany.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Bath PUVA and Saltwater Baths Followed by UV-B Phototherapy as Treatments for Psoriasis: A Randomized Controlled Trial
Schiener et al.
Arch Dermatol 2007;143:586-596.
ABSTRACT
| FULL TEXT
Treatment of Psoriasis With Calcipotriene Plus Psoralen-UV-A-Bath Therapy
Grundmann-Kollmann et al.
Arch Dermatol 1999;135:861-862.
FULL TEXT
Oral Psoralen-UV-A for Systemic Scleroderma
Hofer et al.
Arch Dermatol 1999;135:603-604.
FULL TEXT
Bath Psoralen-UV-A Therapy for Persistent Grover Disease
Luftl et al.
Arch Dermatol 1999;135:606-607.
FULL TEXT
Variations of PUVA: Practical and Effective?
Morison
Arch Dermatol 1998;134:1286-1288.
FULL TEXT
|